Interdisciplinary Program to Improve the Lifestyle of Individuals with Chronic Conditions in the Alt Pirineu and Aran Region Sedentary behavior and lack of regular physical activity have been widely recognized as urgent global public health issues-not only because they are key risk factors for cardiovascular morbidity and mortality, but also due to their impact on major chronic diseases. Primary Objective / Hypothesis To evaluate the effectiveness of an intervention program aimed at improving the lifestyle of individuals with chronic conditions in the Alt Pirineu and Aran health region by promoting active living and physical activity (PA), healthy dietary habits, and positive mental health (PMH), through the use of a digital tool (APP). The program also aims to determine whether this intervention leads to a reduction in cardiovascular risk, comorbidity, and premature aging associated with non-communicable diseases. Study Design and Sample The sample will consist of individuals over 18 years of age with moderate to high cardiovascular risk who voluntarily participate in the project. The program will last for 9 months and will be structured into two groups: an intervention group, which will actively participate in the program through the APP, and a control group, which will not receive the intervention. Pre- and post-intervention measurements will be applied to assess the effects of the program. Applicability and Relevance This project seeks to implement an interdisciplinary care model for individuals with chronic conditions, aiming to enhance lifestyle behaviors, reduce comorbidity, and mitigate premature aging. The APA-fit digital tool seeks to implement this model by empowering patients in their self-care and facilitating seamless, effective communication between patients and healthcare professionals.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline of frecuency and intensity of pysical activity
Timeframe: From enrollment to end of treatment , 9 months
Change from baseline mediterrainian diet on 14 points on the scale of adherence to the Mediterranean diet.
Timeframe: from enrollment to end the treatment. 9 months
Change from baseline of positive mental health based on 18 points of the Positive Mental Health Scale-Revised
Timeframe: From enrollment to end the treatment. 9 months
Change from baseline of the BMI of participants. Weight and height will be combined to report BMI in kg/m^2
Timeframe: From enrollment to end of treatment, 9 months
Height of participants
Timeframe: baseline
Change from baseline of the weight of participants
Timeframe: From enrollment to end of treatment, 9 months
Change from baseline of water percentage with a bioimpedance scale
Timeframe: From enrollment and each 3 month (3, 6, 9)
Change from baseline of fat mass percentage and kg with a bioimpedance scale
Timeframe: From enrollment and each 3 month (3, 6, 9)
Change from baseline of muscle percentage and kg with a bioimpedance scale
Timeframe: From enrollment and each 3 month (3, 6, 9)
Change from baseline of bone percentage and kg with a bioimpedance scale
Timeframe: From enrollment and each 3 month (3, 6, 9)
Change from baseline of fat free mass percentage and kg with a bioimpedance scale
Timeframe: From enrollment and each 3 month (3, 6, 9)
Change in the baseline of the cardiovascular risk index with the waist-hip measurement
Timeframe: From enrollment to end of treatment, 9 months
Change in the baseline of food consumption frequency on 30 points of food consumption frequency questionnaire
Timeframe: From enrollment to end of treatment, 9 months
Number of participants presenting abnormal laboratory results related to lipid profile.
Timeframe: From enrollment to end of treatment, 9 months
Number of participants presenting abnormal laboratory results related to hormone levels.
Timeframe: From enrollment to end of treatment, 9 months
Number of participants presenting abnormal laboratory results related to liver function.
Timeframe: From enrollment to end of treatment, 9 months
Number of participants presenting abnormal laboratory results related to blood glucose level.
Timeframe: From enrollment to end of treatment, 9 months
Number of participants with abnormal laboratory results related to red and white blood cell series, including monocytes, leukocytes, and hematocrit.
Timeframe: From enrollment to end of treatment, 9 months